Healthbook TIMES Oncology Hematology : Impact Factor & More
eISSN: 2673-2106pISSN: 2673-2092
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Healthbook TIMES Oncology Hematology Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | The HealthBook Company Ltd |
| Language | English |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Publisher's own website |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Healthbook TIMES Oncology Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Healthbook TIMES Oncology Hematology
Practical Experience with Automated Technologies in Anti-CD19 CAR T-Cell Product Manufacturing
- 9 Apr 2026
- healthbook TIMES Oncology Hematology
Hormone Replacement Therapy After Endometrial Cancer: Current Evidence and Treatment Recommendations
- 25 Feb 2026
- healthbook TIMES Oncology Hematology
High-Dose Chemotherapy and Stem Cell Transplantation in ZBTB16::RARA Acute Promyelocytic Leukemia: A Case Report
- 23 Feb 2026
- healthbook TIMES Oncology Hematology
Antibody-Drug Conjugate Sequencing in Metastatic Breast Cancer
- 16 Feb 2026
- healthbook TIMES Oncology Hematology
Bridge the Gap to CAR: Bridging Therapy in CAR T-Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- 13 Feb 2026
- healthbook TIMES Oncology Hematology
The Emerging Role of Oral SERDs in Early Breast Cancer
- 13 Feb 2026
- healthbook TIMES Oncology Hematology
Practical Experience with Automated Technologies in Anti-CD19 CAR T-Cell Product Manufacturing
- 9 Apr 2026
- healthbook TIMES Oncology Hematology
Hormone Replacement Therapy After Endometrial Cancer: Current Evidence and Treatment Recommendations
- 25 Feb 2026
- healthbook TIMES Oncology Hematology
High-Dose Chemotherapy and Stem Cell Transplantation in ZBTB16::RARA Acute Promyelocytic Leukemia: A Case Report
- 23 Feb 2026
- healthbook TIMES Oncology Hematology
Antibody-Drug Conjugate Sequencing in Metastatic Breast Cancer
- 16 Feb 2026
- healthbook TIMES Oncology Hematology
Bridge the Gap to CAR: Bridging Therapy in CAR T-Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- 13 Feb 2026
- healthbook TIMES Oncology Hematology
The Emerging Role of Oral SERDs in Early Breast Cancer
- 13 Feb 2026
- healthbook TIMES Oncology Hematology
FAQs on Healthbook TIMES Oncology Hematology
How many articles did Healthbook TIMES Oncology Hematology publish last year? 
What is the eISSN & pISSN for Healthbook TIMES Oncology Hematology?
Who is the publisher of Healthbook TIMES Oncology Hematology?
